Association of genotype with treatment response and prognosis in dilated cardiomyopathy
Revista Española de Cardiología (English Edition) · 2025
DOI: 10.1016/j.rec.2025.10.002 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Revista Española de Cardiología (English Edition), 2025. Verfasst von Nerea Mora-Ayestarán und 34 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Cardiología, Hospital Universitario Puerta de Hierro Majadahonda, Instituto Investigación Sanitaria Puerta de Hierro - Segovia de Ara…. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Ventricular Remodeling, Ventricular Function, Left, DNA. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ISCIII, European Social Fund Plus, European Regional Development Fund.
Abstract (Originalsprache)
INTRODUCTION AND OBJECTIVES: Left ventricular reverse remodeling (LVRR) is a key therapeutic goal in dilated cardiomyopathy (DCM). However, its genetic predictors and prognostic impact remain uncertain. METHODS: We analyzed genotyped DCM patients with serial echocardiograms from the Spanish DCM study. The main objective was to assess the influence of genotype on LVRR, defined by improvement in ejection fraction within 12± 6 months. Secondary endpoints included major adverse cardiovascular events, end-stage heart failure (HF), and major ventricular arrhythmias. RESULTS: A total of 711 patients were included (67% male, mean age 50.8 years, baseline ejection fraction 31%, 44% genotype positive). LVRR occurred in 39% of genotype-positive vs 47% of genotype-negative patients (P=.036). Independent predictors of LVRR were TTN variants, lower baseline ejection fraction, and HF admission at diagnosis. In contrast, desmosomal, nuclear envelope and motor sarcomeric gene variants were associated with a lower likelihood of LVRR. During a median follow-up of 4.5 years, 26% of patients with initial LVRR showed subsequent deterioration, which was more frequent among genotype-positive individuals (32% vs 22%, P=.054). Compared with patients with sustained LVRR, those with deterioration had worse outcomes, including higher rates of major cardiovascular events (25% vs 7%), end-stage HF (18% vs 1%), and ventricular arrhythmia (12% vs 4%) (all P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Cardiología, Hospital Universitario Puerta de Hierro Majadahonda, Instituto Investigación Sanitaria Puerta de Hierro - Segovia de Arana (IDIPHISA), Majadahonda, Madrid, Spain; Centro de Investigación Bio…
- Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain; European Reference Network for Rare, Low Prevalence, and Complex Diseases of the Heart (…
- Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain; Departamento de Cardiología, Hospital Universitario de Salamanca, Gerencia Regional de S…
- Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain; Unidad de Insuficiencia Cardíaca Avanzada y Trasplante Cardíaco, Instituto de Investigac…
- Unidad de Enfermedades Cardiovasculares Hereditarias, Departamento de Cardiología, Hospital General Universitario Dr. Balmis de Alicante, Institute of Health and Biomedical Research, Alicante, Spain; Instituto de Invest…
Förderung
- ISCIII
- European Social Fund Plus
- European Regional Development Fund
- Computer Network Information Center, Chinese Academy of Sciences
Zitieren
APA
Mora-Ayestarán, N., Ochoa, J. P., Espinosa-Castro, M. Á., Navarro-Peñalver, M., Villacorta, E., Crespo-Leiro, M. G., Climent-Payá, V., Lacuey-Lecumberri, G., Peña-Peña, M. L., Bermúdez-Jiménez, F. J., García-Pinilla, J. M., Mogollón-Jiménez, M. V., Limeres-Freire, J., García-Álvarez, A., Bayés-Genís, A., Palomino-Doza, J., Tirón, C., Ripoll-Vera, T., López, J., …, & Domínguez, F. (2025). Association of genotype with treatment response and prognosis in dilated cardiomyopathy. Revista Española de Cardiología (English Edition). https://doi.org/10.1016/j.rec.2025.10.002
Vancouver
Mora-Ayestarán N, Ochoa JP, Espinosa-Castro MÁ, Navarro-Peñalver M, Villacorta E, Crespo-Leiro MG, et al. Association of genotype with treatment response and prognosis in dilated cardiomyopathy. Revista Española de Cardiología (English Edition). 2025. doi:10.1016/j.rec.2025.10.002
BibTeX
@article{MoraAyestarn2025,
author = {Mora-Ayestarán, Nerea and Ochoa, Juan Pablo and Espinosa-Castro, María Ángeles and Navarro-Peñalver, Marina and Villacorta, Eduardo and Crespo-Leiro, María G and Climent-Payá, Vicente and Lacuey-Lecumberri, Gemma and Peña-Peña, María Luisa and Bermúdez-Jiménez, Francisco J and García-Pinilla, José M and Mogollón-Jiménez, María Victoria and Limeres-Freire, Javier and García-Álvarez, Ana and Bayés-Genís, Antoni and Palomino-Doza, Julián and Tirón, Coloma and Ripoll-Vera, Tomás and López, Javier and Brion, María and Vilches-Soria, Silvia and Sabater-Molina, María and García-Berrocal, Belén and Larrañaga-Moreira, José M and García-Álvarez, María I and Basurte-Elorz, María Teresa and Llamas-Gómez, Helena and Méndez-Fernández, Irene and Garrido-Bravo, Iris Paula and González-López, Esther and Gallego-Delgado, María and Barriales-Villa, Roberto and Lara-Pezzi, Enrique and García-Pavía, Pablo and Domínguez, Fernando},
title = {Association of genotype with treatment response and prognosis in dilated cardiomyopathy},
journal = {Revista Española de Cardiología (English Edition)},
year = {2025},
doi = {10.1016/j.rec.2025.10.002}
}
EUVIMED